(VIANEWS) – iRadimed Corporation (IRMD), InMode Ltd. (INMD), Surgery Partners (SGRY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. iRadimed Corporation (IRMD)
21% sales growth and 18.96% return on equity
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Earnings Per Share
As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.1.
PE Ratio
iRadimed Corporation has a trailing twelve months price to earnings ratio of 30.19. Meaning,
the purchaser of the share is investing $30.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.96%.
Yearly Top and Bottom Value
iRadimed Corporation’s stock is valued at $33.21 at 19:22 EST, way under its 52-week high of $55.92 and way above its 52-week low of $26.00.
2. InMode Ltd. (INMD)
19.9% sales growth and 39.56% return on equity
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.
Earnings Per Share
As for profitability, InMode Ltd. has a trailing twelve months EPS of $2.05.
PE Ratio
InMode Ltd. has a trailing twelve months price to earnings ratio of 16.89. Meaning,
the purchaser of the share is investing $16.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.56%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 4.7% and 15%, respectively.
Volume
Today’s last reported volume for InMode Ltd. is 1152720 which is 14% below its average volume of 1340410.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.7%, now sitting on 431.24M for the twelve trailing months.
Moving Average
InMode Ltd. ‘s value is below its 50-day moving average of $35.88 and way higher than its 200-day moving average of $30.91.
3. Surgery Partners (SGRY)
11.8% sales growth and 4.95% return on equity
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Earnings Per Share
As for profitability, Surgery Partners has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.95%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Surgery Partners’s EBITDA is 50.75.
Moving Average
Surgery Partners’s worth is way higher than its 50-day moving average of $28.31 and under its 200-day moving average of $33.01.
4. Unifirst Corporation (UNF)
6.3% sales growth and 5.4% return on equity
UniFirst Corporation provides workplace uniforms and protective work wear clothing in the United States, Europe, and Canada. The company operates through U.S. and Canadian Rental and Cleaning, Manufacturing, Specialty Garments Rental and Cleaning, and First Aid segments. It designs, manufactures, personalizes, rents, cleans, delivers, and sells a range of uniforms and protective clothing, including shirts, pants, jackets, coveralls, lab coats, smocks, and aprons; and specialized protective wear, such as flame resistant and high visibility garments. The company also rents and sells industrial wiping products, floor mats, facility service products, and dry and wet mops; restroom and cleaning supplies comprising air fresheners, paper products, gloves, masks, sanitizers, and hand soaps; and other textile products. In addition, it provides first aid cabinet services and other safety supplies; decontaminates and cleans work clothes, and other items that is exposed to radioactive materials; and services special cleanroom protective wear and facilities. Further, it offers a range of garment service options, including full-service rental programs in which garments are cleaned and serviced; lease programs in which garments are cleaned and maintained by individual employees; and purchase programs to buy garments and related items directly. The company serves automobile service centers and dealers, delivery services, food and general merchandise retailers, food processors and service operations, light manufacturers, maintenance facilities, restaurants, service companies, soft and durable goods wholesalers, transportation companies, healthcare providers, government agencies, research and development laboratories, high technology companies, and utilities operating nuclear reactors, as well as others who require employee clothing for image, identification, protection, or utility purposes. UniFirst Corporation was founded in 1936 and is headquartered in Wilmington, Massachusetts.
Earnings Per Share
As for profitability, Unifirst Corporation has a trailing twelve months EPS of $5.5.
PE Ratio
Unifirst Corporation has a trailing twelve months price to earnings ratio of 37.06. Meaning,
the purchaser of the share is investing $37.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Unifirst Corporation’s EBITDA is 1.63.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 11.3% and 11.9%, respectively.
